The modulation of STAT5A/GR complexes during fat cell differentiation and in mature adipocytes

Obesity

Volumn 15, Issue 3, 2007, Pages 583-590

  Baugh Jr , James E ^a   Floyd, Z Elizabeth ^a   Stephens, Jacqueline M ^a  

^a LOUISIANA STATE UNIVERSITY   (United States)

Author keywords

Adipocytes; Adipogenesis; Glucocorticoids

Indexed keywords

GLUCOCORTICOID RECEPTOR; GROWTH HORMONE; STAT5 PROTEIN; STAT5A PROTEIN, MOUSE; UNCLASSIFIED DRUG;

ADIPOCYTE; ADIPOGENESIS; ANIMAL; ARTICLE; BIOLOGICAL MODEL; CELL DIFFERENTIATION; CELL LINE; CELL NUCLEUS; CELL STRAIN 3T3; CYTOLOGY; DRUG EFFECT; GENE EXPRESSION REGULATION; METABOLISM; MOUSE; PHYSIOLOGY; PROTEIN BINDING;

3T3-L1 CELLS; ADIPOCYTES; ADIPOGENESIS; ANIMALS; CELL DIFFERENTIATION; CELL LINE; CELL NUCLEUS; GENE EXPRESSION REGULATION; GROWTH HORMONE; MICE; MODELS, BIOLOGICAL; PROTEIN BINDING; RECEPTORS, GLUCOCORTICOID; STAT5 TRANSCRIPTION FACTOR;

EID: 34247345380     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2007.500     Document Type: Article

References (26)

1. Beato M, Herrlich P, Schutz G. Steroid hormone receptors: many actors in search of a plot. Cell. 1995;83:851-7.
2. Reichardt HM, Schutz G. Glucocorticoid signaling: multiple variations of a common theme. Mol Cell Endocrinol. 1998; 146:1-6.
3. Dobson MG, Redfern CP, Unwin N, Weaver JU. The N363S polymorphism of the glucocorticoid receptor: potential contribution to central obesity in men and lack of association with other risk factors for coronary heart disease and diabetes mellitus. J Clin Endocrinol Metab. 2001;86:2270-4.
4. Ukkola O, Bouchard C. Clustering of metabolic abnormalities in obese individuals: the role of genetic factors. Ann Med. 2001;33:79-90.
5. Rosmond R, Bouchard C, Björntorp P. Tsp509I polymorphism in exon 2 of the glucocorticoid receptor gene in relation to obesity and cortisol secretion: cohort study. BMJ. 2001; 322:652-3.
6. Golub MS. The adrenal and the metabolic syndrome. Curr Hypertens Rep. 2001;3:117-20.
7. Kellendonk C, Eiden S, Kretz O, et al. Inactivation of the GR in the nervous system affects energy accumulation. Endocrinology. 2002;143:2333-40.
8. Ljung T, Ottosson M, Ahlberg AC, et al. Central and peripheral glucocorticoid receptor function in abdominal obesity. J Endocrinol Invest. 2002;25:229-35.
9. Stocklin E, Wissler M, Gouilleux F, Groner B. Functional interactions between Stat5 and the glucocorticoid receptor. Nature. 1996;383:726-8.
10. Schmitt-Ney M, Doppler W, Ball RK, Groner B. Beta-casein gene promoter activity is regulated by the hormone-mediated relief of transcriptional repression and a mammary-gland-specific nuclear factor. Mol Cell Biol. 1991;11: 3745-55.
11. Wakao H, Gouilleux F, Groner B. Mammary gland factor (MGF) is a novel member of the cytokine regulated transcription factor gene family and confers the prolactin response. EMBO J. 1994;13:2182-91.
12. Kisseleva T, Bhattacharya S, Braunstein J, Schindler CW. Signaling through the JAK/STAT pathway, recent advances and future challenges. Gene. 2002;285:1-24.
13. Teglund S, McKay C, Schuetz E, et al. Stat5a and StatSb proteins have essential and nonessential, or redundant, roles in cytokine responses. Cell. 1998;93:841-50.
14. Stephens JM, Morrison RF, Pilch PF. The expression and regulation of STATs during 3T3-L1 adipocyte differentiation. J Biol Chem. 1996;271:10441-4.
15. Yarwood SJ, Sale EM, Sale GJ, Houslay MD, Kilgour E, Anderson NG. Growth hormone-dependent differentiation of 3T3-F442A preadipocytes requires Janus kinase/signal transducer and activator of transcription but not mitogen-activated protein kinase or p70 S6 kinase signaling. J Biol Chem. 1999;274:8662-8.
16. Shang CA, Waters MJ. Constitutively active signal transducer and activator of transcription 5 can replace the requirement for growth hormone in adipogenesis of 3T3-F442A preadipocytes. Mol Endocrinol. 2003; 17:2494-508.
17. Floyd ZE, Stephens JM. STAT5A promotes adipogenesis in nonprecursor cells and associates with the glucocorticoid receptor during adipocyte differentiation. Diabetes. 2003;52: 308-14.
18. Richter HE, Albrektsen T, Billestrup N. The role of signal transducer and activator of transcription 5 in the inhibitory effects of GH on adipocyte differentiation. J Mol Endocrinol. 2003;30:139-50.
19. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227: 680-5.
20. Lechner J, Weite T, Tomasi JK, et al. Promoter-dependent synergy between glucocorticoid receptor and Stat5 in the activation of beta-casein gene transcription. J Biol Chem. 1997;272:20954-60.
21. Cella N, Groner B, Hynes NE. Characterization of Stat5a and Stat5b homodimers and heterodimers and their association with the glucocorticoid receptor in mammary cells. Mol Cell Biol. 1998;18:1783-92.
22. Biola A, Lefebvre P, Perrin-Wolff M, Sturm M, Bertoglio J, Pallardy M. Interleukin-2 inhibits glucocorticoid receptor transcriptional activity through a mechanism involving STATS (signal transducer and activator of transcription 5) but not AP-1. Mol Endocrinol. 2001;15:1062-76.
23. Tronche F, Opherk C, Moriggl R, et al. Glucocorticoid receptor function in hepatocytes is essential to promote postnatal body growth. Genes Dev. 2004;18:492-7.
24. Doppler W, Windegger M, Soratroi C, et al. Expression level-dependent contribution of glucocorticoid receptor domains for functional interaction with STAT5. Mol Cell Biol. 2001;21:3266-79.
25. Wyszomierski SL, Yeh J, Rosen JM. Glucocorticoid receptor/signal transducer and activator of transcription 5 (STAT5) interactions enhance STAT5 activation by prolonging STAT5 DNA binding and tyrosine phosphorylation. Mol Endocrinol. 1999;13:330-43.
26. Udy GB, Towers RP, Snell RG, et al. Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression. Proc Natl Acad Sci USA. 1997;94:7239-44.